Biblio

Export 1382 results:
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is G  [Clear All Filters]
Journal Article
K. Iqbal, Liu, F., Gong, C. - X., and Grundke-Iqbal, I., “Tau in Alzheimer disease and related tauopathies.”, Curr Alzheimer Res, vol. 7, no. 8, pp. 656-64, 2010.
C. M. Roe, Babulal, G. M., Mishra, S., Gordon, B. A., Stout, S. H., Ott, B. R., Carr, D. B., Ances, B. M., Morris, J. C., and Benzinger, T. L. S., “Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 509-513, 2018.
S. Gauthier, Ng, K. Pin, Pascoal, T. A., Zhang, H., and Rosa-Neto, P., “Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.”, J Alzheimers Dis, vol. 64, no. s1, pp. S23-S31, 2018.
E. L. Boespflug, Simon, M. J., Leonard, E., Grafe, M., Woltjer, R., Silbert, L. C., Kaye, J. A., and Iliff, J. J., “Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1587-1597, 2018.
D. Gouilly, Tisserand, C., Nogueira, L., Saint-Lary, L., Rousseau, V., Benaiteau, M., Rafiq, M., Carlier, J., Milongo-Rigal, E., Pagès, J. - C., and Pariente, J., “Taking the A Train? Limited Consistency of Aβ42 and the Aβ42/40 Ratio in the AT(N) Classification.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1033-1038, 2021.
S. Martínez-López, Tabone, M., Clemente-Velasco, S., González-Soltero, M. Del Rocío, Bailén, M., de Lucas, B., Bressa, C., Domínguez-Balmaseda, D., Marín-Muñoz, J., Antúnez, C., Gálvez, B. G., and Larrosa, M., “A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials.”, J Alzheimers Dis, vol. 102, no. 4, pp. 943-966, 2024.
S. Martínez-López, Tabone, M., Clemente-Velasco, S., González-Soltero, M. Del Rocío, Bailén, M., de Lucas, B., Bressa, C., Domínguez-Balmaseda, D., Marín-Muñoz, J., Antúnez, C., Gálvez, B. G., and Larrosa, M., “A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials.”, J Alzheimers Dis, vol. 102, no. 4, pp. 943-966, 2024.
L. Sannemann, Bartels, C., Brosseron, F., Buerger, K., Fliessbach, K., Freiesleben, S. Dawn, Frommann, I., Glanz, W., Heneka, M. T., Janowitz, D., Kilimann, I., Kleineidam, L., Lammerding, D., Laske, C., Munk, M. H. J., Perneczky, R., Peters, O., Priller, J., Rauchmann, B. - S., Rostamzadeh, A., Roy-Kluth, N., Schild, A. - K., Schneider, A., Schneider, L. - S., Spottke, A., Spruth, E. Jakob, Teipel, S., Wagner, M., Wiltfang, J., Wolfsgruber, S., Duezel, E., and Jessen, F., “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
Y. Yu, Gao, Y., Winblad, B., Tjernberg, L. O., and Schedin-Weiss, S., “A Super-Resolved View of the Alzheimer's Disease-Related Amyloidogenic Pathway in Hippocampal Neurons.”, J Alzheimers Dis, vol. 83, no. 2, pp. 833-852, 2021.
E. C. Edmonds, Delano-Wood, L., Galasko, D. R., Salmon, D. P., and Bondi, M. W., “Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 1, pp. 231-42, 2015.
L. A. Digma, Winer, J. R., and Greicius, M. D., “Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies.”, J Alzheimers Dis, vol. 97, no. 2, pp. 567-572, 2024.
C. Ramos, Villalba, C., García, J., Lanata, S., López, H., Aguillón, D., Cordano, C., Madrigal, L., Aguirre-Acevedo, D. C., and Lopera, F., “Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study.”, J Alzheimers Dis, vol. 85, no. 4, pp. 423-1439, 2021.
Z. Z. Zlatar, Muniz, M. C., Espinoza, S. G., Gratianne, R., Gollan, T. H., Galasko, D., and Salmon, D. P., “Subjective Cognitive Decline, Objective Cognition, and Depression in Older Hispanics Screened for Memory Impairment.”, J Alzheimers Dis, vol. 63, no. 3, pp. 949-956, 2018.
Z. Z. Zlatar, Muniz, M. C., Espinoza, S. G., Gratianne, R., Gollan, T. H., Galasko, D., and Salmon, D. P., “Subjective Cognitive Decline, Objective Cognition, and Depression in Older Hispanics Screened for Memory Impairment.”, J Alzheimers Dis, vol. 63, no. 3, pp. 949-956, 2018.
Z. Z. Zlatar, Muniz, M. C., Espinoza, S. G., Gratianne, R., Gollan, T. H., Galasko, D., and Salmon, D. P., “Subjective Cognitive Decline, Objective Cognition, and Depression in Older Hispanics Screened for Memory Impairment.”, J Alzheimers Dis, vol. 63, no. 3, pp. 949-956, 2018.
J. I. Ali, Smart, C. M., and Gawryluk, J. R., “Subjective Cognitive Decline and APOE ɛ4: A Systematic Review.”, J Alzheimers Dis, vol. 65, no. 1, pp. 303-320, 2018.
N. E. Gray, Zweig, J. A., Kawamoto, C., Quinn, J. F., and Copenhaver, P. F., “STX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-β Toxicity.”, J Alzheimers Dis, vol. 51, no. 2, pp. 391-403, 2016.
A. Tucholka, Grau-Rivera, O., Falcon, C., Rami, L., Sánchez-Valle, R., Lladó, A., Gispert, J. Domingo, and Molinuevo, J. Luis, “Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1575-1587, 2018.
A. Tucholka, Grau-Rivera, O., Falcon, C., Rami, L., Sánchez-Valle, R., Lladó, A., Gispert, J. Domingo, and Molinuevo, J. Luis, “Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1575-1587, 2018.
A. Kapoor, Bartha, R., Black, S. E., Borrie, M., Freedman, M., Gao, F., Herrmann, N., Mandzia, J., Ozzoude, M., Ramirez, J., Scott, C. J. M., Symons, S., Fischer, C. E., Frank, A., Seitz, D., Wolf, M. Uri, Verhoeff, N. Paul L. G., Naglie, G., Reichman, W., Masellis, M., Mitchell, S. B., Tang-Wai, D. F., Tartaglia, M. Carmela, Kumar, S., Pollock, B. G., Rajji, T. K., Finger, E., Pasternak, S. H., and Swartz, R. H., “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
C. Domínguez-Vivero, Wu, L., Lee, S., Manoochehri, M., Cines, S., Brickman, A. M., Rizvi, B., Chesebro, A., Gazes, Y., Fallon, E., Lynch, T., Heidebrink, J. L., Paulson, H., Goldman, J. S., Huey, E., and Cosentino, S., “Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.”, J Alzheimers Dis, vol. 75, no. 2, pp. 595-606, 2020.
C. Domínguez-Vivero, Wu, L., Lee, S., Manoochehri, M., Cines, S., Brickman, A. M., Rizvi, B., Chesebro, A., Gazes, Y., Fallon, E., Lynch, T., Heidebrink, J. L., Paulson, H., Goldman, J. S., Huey, E., and Cosentino, S., “Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.”, J Alzheimers Dis, vol. 75, no. 2, pp. 595-606, 2020.
Y. - T. Dong, Cao, K., Tan, L. - C., Wang, X. - L., Qi, X. - L., Xiao, Y., and Guan, Z. - Z., “Stimulation of SIRT1 Attenuates the Level of Oxidative Stress in the Brains of APP/PS1 Double Transgenic Mice and in Primary Neurons Exposed to Oligomers of the Amyloid-β Peptide.”, J Alzheimers Dis, vol. 63, no. 1, pp. 283-301, 2018.
V. K. Ramanan, Przybelski, S. A., Graff-Radford, J., Castillo, A. M., Lowe, V. J., Mielke, M. M., Roberts, R. O., Reid, R. I., Knopman, D. S., Jack, C. R., Petersen, R. C., and Vemuri, P., “Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1345-1352, 2018.
A. Chincarini, Sensi, F., Rei, L., Bossert, I., Morbelli, S., Guerra, U. Paolo, Frisoni, G., Padovani, A., and Nobili, F., “Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1437-1457, 2016.

Pages